Literature DB >> 7885194

Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes.

C Mignat1, U Wille, A Ziegler.   

Abstract

The affinity of morphine, codeine, dihydrocodeine and their glucuronides for mu-, delta-, and kappa-opioid receptors was investigated. Binding was studied on guinea-pig brain homogenates with [3H]DAMGO, [3H]DPDPE, and [3H]U69593. The substitution of the free phenolic group of morphine caused a decrease in binding at opioid receptors without affecting the mu/delta-ratio nor that of mu/kappa. Glucuronidation of the 6-hydroxyl group of morphine, codeine or dihydrocodeine did not affect the affinity to mu-receptors, slightly increased the affinity for delta-receptors and reduced the affinity for kappa-receptors. The 6-glucuronides possess a decreased selectivity for mu-receptors over delta-receptors whereas that for mu- over kappa-receptors was increased. It is concluded that chemical variations at 3- and 6-position of morphine independently affect the affinity to opioid receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7885194     DOI: 10.1016/0024-3205(95)00010-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  34 in total

1.  Morphine-6 beta-glucuronide has a higher efficacy than morphine as a mu-opioid receptor agonist in the rat locus coeruleus.

Authors:  P B Osborne; B Chieng; M J Christie
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  Role of active metabolites in the use of opioids.

Authors:  Janet K Coller; Lona L Christrup; Andrew A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  2008-10-29       Impact factor: 2.953

3.  Fischer rats are more sensitive than Lewis rats to the suppressive effects of morphine and the aversive kappa-opioid agonist spiradoline.

Authors:  Christopher S Freet; Robert A Wheeler; Ellen Leuenberger; Nicole A S Mosblech; Patricia S Grigson
Journal:  Behav Neurosci       Date:  2013-10       Impact factor: 1.912

4.  Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranes.

Authors:  S V Löser; J Meyer; S Freudenthaler; M Sattler; C Desel; I Meineke; U Gundert-Remy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

Review 5.  The black box of perinatal ischemic stroke pathogenesis.

Authors:  Aleksandra Mineyko; Adam Kirton
Journal:  J Child Neurol       Date:  2011-06-13       Impact factor: 1.987

6.  Differential responses of brain, liver, and muscle glycogen to opiates and surgical stress.

Authors:  Y Hashiguchi; P E Molina; R Boxer; R Naukam; N N Abumrad
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

7.  Affinity profiles of novel delta-receptor selective benzofuran derivatives of non-peptide opioids.

Authors:  M Spetea; S T Nevin; S Hosztafi; A Z Rónai; G Tóth; A Borsodi
Journal:  Neurochem Res       Date:  1998-09       Impact factor: 3.996

8.  In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor function.

Authors:  Mariana Spetea; Catalina R Bohotin; Muhammad F Asim; Kurt Stübegger; Helmut Schmidhammer
Journal:  Eur J Pharm Sci       Date:  2010-06-18       Impact factor: 4.384

9.  Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity.

Authors:  Nicholas M Graziane; Abigail M Polter; Lisa A Briand; R Christopher Pierce; Julie A Kauer
Journal:  Neuron       Date:  2013-03-06       Impact factor: 17.173

10.  Comparison between dexmedetomidine and remifentanil infusion in emergence agitation during recovery after nasal surgery: A randomized double-blind trial.

Authors:  R Polat; K Peker; I Baran; G Bumin Aydın; Ç Topçu Gülöksüz; A Dönmez
Journal:  Anaesthesist       Date:  2015-09-02       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.